Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.

Saved in:
Bibliographic Details
Title: Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.
Authors: Earla JR; Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA. jagadeswara.rao.earla@merck.com., Kurian AW; Stanford University, Stanford, CA, USA., Kponee-Shovein K; Analysis Group, Inc, Boston, MA, USA., Mahendran M; Analysis Group, Inc, Boston, MA, USA., Song Y; Analysis Group, Inc, Boston, MA, USA., Hua Q; Analysis Group, Inc, Boston, MA, USA., Hilts A; Analysis Group, Inc, Boston, MA, USA., Sun Y; Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA., Hirshfield KM; Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA., Robson M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mejia JA; Merck & Co., Inc., 90 E Scott Ave, Rahway, NJ, 07065, USA.
Source: Advances in therapy [Adv Ther] 2025 Feb; Vol. 42 (2), pp. 886-903. Date of Electronic Publication: 2024 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-8652
DOI:10.1007/s12325-024-03074-7